MRI aspects of secondary progressive multiple sclerosis

Wolinsky JS. Multiple sclerosis. In Current Neurology, 1993 Vol 13, ed. Appel SH. Chicago: Mosby-Year Book, Inc. , pp 167-207.

Jacobs LD , Beck RW , Simon JH , et al. Intramuscular inter-feron beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group . N Engl J Med 2000; 343: 898-904 .

Comi G , Filippi M , Barkhof F , et al. Effect of early inter-feron treatment on conversion to definite multiple sclerosis: A randomised study . Lancet 2001; 357: 1576-1582 .

Lublin FD , Reingold SC. Defining the clinical course of multiple sclerosis: Results of an international survey . Neurology 1996; 46: 907-911 .

Whitaker JN , Kachelhofer RD , Bradley EL , et al. Urinary myelin basic protein-like material as a correlate of the progression of multiple sclerosis . Ann Neurol 1995; 38: 625-632 .

Beck RW , Cleary PA , Trobe JD , et al. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group . New Engl J Med 1993; 329: 1764-1769 .

Filippi M , Horsfield MA , Morrissey SP , et al. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis . Neurology 1994; 44: 635-641 .

Noseworthy JH , Wolinsky JS , Lublin FD , et al. Linomide in relapsing and secondary progressive MS: Trial design and clinical results . Neurology 2000; 54: 1726-1733 .

Wolinsky JS , Narayana PA , Noseworthy JH , et al. Linomide in relapsing and secondary progressive MS: MRI results . Neurology 2000; 54: 1734-1741 .

European Study Group on interferon beta-1b in secondary progressive MS. Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis . Lancet 1998; 352: 1491-1497 .

Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-beta-1a in MS (SPECTRIMS) Study Group . Randomized controlled trial of interferon-beta-1a in secondary progressive MS: Clinical results . Neurology 2001; 56: 1496-1504 .

Kappos L , Moeri D , Radue EW , et al. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: A meta-analysis . Lancet 1999; 353: 964-969 .

Van Walderveen MAA , Lycklama a Nijeholt GJ , Ader HJ , et al. Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging—Relation to clinical characteristics in subgroups of patients with multiple sclerosis . Arch Neurol 2001; 58: 76-81 .

van Walderveen MA , Kamphorst W , Scheltens P , et al. Histopathologic correlate of hypointense lesions on T1- weighted spin-echo MRI in multiple sclerosis . Neurology 1998; 50: 1282-1288 .

van Waesberghe JH , van Walderveen MA , Castelijns JA , et al. Patterns of lesion development in multiple sclerosis: Longitudinal observations with T1-weighted spin-echo and magnetization transfer MR . AJNR 1998; 19: 675-683 .

Filippi M , Rovaris M , Rocca MA , Sormani MP , Wolinsky JS , Comi G , et al. Glatiramer acetate reduces the proportion of new MS lesions evolving into ‘black holes’ . Neurology 2001; (in press).

Filippi M , Wolinsky JS , Sormani MP , Comi G , et al. Enhancement frequency decreases with increasing age in relapsing-remitting multiple sclerosis . Neurology 2001; 56: 422-423 .

Goodkin DE , Rooney WD , Sloan R , et al. A serial study of new MS lesions and the white matter from which they arise . Neurology 1998; 51: 1689-1697 .

Silver NC , Tofts PS , Symms MR , Barker GJ , Thompson AJ , Miller DH. Quantitative contrast-enhanced magnetic resonance imaging to evaluate blood-brain barrier integrity in multiple sclerosis: A preliminary study . Multiple Sclerosis 2001; 7: 75-82 .

McGowan JC , Filippi M , Campi A , Grossman RI. Magnetisation transfer imaging: Theory and application to multiple sclerosis . J Neurol Neurosurg Psych 1998; 64(Suppl 1): S66-S69 .

Richert ND , Ostuni JL , Bash CN , Leist TP , McFarland HF , Frank JA. Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis . Multiple Sclerosis 2001; 7: 49-58 .

Filippi M , Iannucci G , Tortorella C , et al. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI . Neurology 1999; 52: 588-594 .

Rocca MA , Mastronardo G , Rodegher M , Comi G , Filippi M. Long-term changes of magnetization transfer-derived measures from patients with relapsing-remitting and secondary progressive multiple sclerosis . AJNR 1999; 20: 821-827 .